Most Recent
The former general manager of sales for Fiat Chrysler Australia has sued the car company for allegedly terminating him for taking two periods of leave after being diagnosed with an auto-immune condition.
Liberty Financial unit Minerva has challenged a judgment that found two schemes it carried out were done with the primary purpose of securing a tax advantage.
A second securities class action has been filed against failed Blue Sky Alternative Investments and auditor EY alleging financial reports materially overstated the health of the asset manager ahead of its collapse three years ago.
Media company The Economist has failed in its opposition to registration of a trade mark for The Beer Economist, with an IP Australia delegate saying the mark was not substantially identical or deceptively similar to the UK publisher's brand.
Victoria's gambling regulator has slapped Crown Resorts with $120 million in fines for falling short in its obligation to supervise problem gambling, in what the regulator called "extensive, sustained and systemic failures" spanning 12 years.
Medibank will not pay a ransom to a criminal who stole the data of 9.7 million customers, saying it would encourage extortion.
White shoe firm White & Case has lured a partner from Norton Rose Fulbright to beef up its competition capabilities in Australia.
The Commonwealth Bank of Australia faces trial Monday in one of several class actions filed against a major Australian company in recent years over allegedly lax money laundering practices and disclosures.
Fintech iSignthis has dropped a $464 million lawsuit brought against the Australian Stock Exchange three years ago over allegedly misleading conduct in relation to the suspension of the company's shares.
Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant's trade marks should be cancelled because they're too generic and are being used to sell products that don't exclusively contain the a2 protein.